The North
America Molecular Diagnostics Market report discusses the primary market growth drivers and challenges that
the vendors and the market as a whole face and provides an overview of the key
trends emerging in the market. It also talks about the market size of different
segments and their growth aspects along with key leading countries in Americas,
Asia-Pacific, Europe, the Middle East, and Africa regions.
North America Molecular Diagnostics Market is expected to reach USD 7.2
billion by 2024. Molecular diagnostics is a branch of clinical pathology or
laboratory medicine that uses techniques of molecular biology to diagnose
disease, monitor the effectiveness of therapies, predict diseases course, and
select therapy. North America molecular diagnostics industry is estimated to
grow at a significant CAGR in the upcoming period as the scope and its
applications are increasing enormously.
Download
Free Sample Report Now @ https://www.millioninsights.com/industry-reports/north-america-molecular-diagnostics-market/request-sample
Some of the major objectives of this
report:
1. To provide detailed analysis of the market
structure along with forecast of the various segments and sub-segments of the
global North America Molecular Diagnostics Market.
2. To provide insights about factors
affecting the market growth. To analyze the North America Molecular Diagnostics
Market based on various factors- price analysis, supply chain analysis, porter
five force analysis etc.
3. To provide historical and forecast revenue
of the North America Molecular Diagnostics Market segments and sub-segments
with respect to four main geographies and their countries- North America,
Europe, Asia, and Rest of the World.
4. Country level analysis of the market with
respect to the current market size and future prospective.
5. To provide country level analysis of the
market for segment by application, product type and sub-segments.
6. To provide strategic profiling of key
players in the market, comprehensively analyzing their core competencies, and
drawing a competitive landscape for the market.
7. Track and analyze
competitive developments such as joint ventures, strategic alliances, mergers
and acquisitions, new product developments, and research and developments in
the global North America Molecular Diagnostics Market.
The factors that are playing a major role in the growth of North
American molecular diagnostics market area technological enhancement in
molecular diagnostic kits and rising R&D activities by manufacturers. North
America molecular diagnostics market is segmented based on product type, rest
location, technology, application, and region.
Reagents, instruments, and the other product types could be explored in
North American molecular diagnostics in the forecast period. Reagents sector
accounted for the significant market share of North America molecular
diagnostics and is estimated to continue with its dominance in the years to
come. The reason could be increasing use of these tests in a nonmedical sector
like home and molecular diagnostic sector.
Central laboratories, point-of-care, self-test, and others could be
explored in North America molecular diagnostics in the forecast period. Central
laboratories sector accounted for the significant market share of North America
molecular diagnostics. The reason behind the overall market growth could be the
presence of ancillary support. In addition, the point-of-care sector is
estimated to grow at the highest CAGR in the years to come.
The market could be categorized based on applications like microbiology,
oncology, cardiovascular disease, pharmacogenomics, neurological disease,
infectious disease, genetic testing, and others could be explored in the
forecast period. Oncology sector accounted for the substantial market share of
North America molecular diagnostics and is estimated to continue its dominance
in the years to come. The reason could be the rising occurrence of cancer and
increasing enhanced diagnostic tests. The sector is also estimated to grow at
the highest CAGR in the years to come.
The United States accounted for the substantial market share of North
America molecular diagnostics and is estimated to lead the overall market in
the years to come. The reason behind the overall market growth could be the
presence of key manufacturers in this region and raised awareness of
personalized medicines. Canada is estimated to follow the suit.
The key players of North America molecular diagnostics market are
QIAGEN, Abbott Laboratories, Dako, Roche Diagnostics, Danaher Corporation,
Hologic, Inc., Dickinson and Company (BD), Novartis AG, BioMérieux SA, Bio-Rad
Laboratories, Inc., Siemens Healthineers GmbH, Alere, Sysmex Corporation, and
Johnson & Johnson Services, Inc. These players are concentrating on
inorganic growth to sustain themselves amidst fierce competition.
Know More Insights
@ https://latestmarketstudy.wordpress.com
No comments:
Post a Comment